Literature DB >> 33801441

The Nerves to Conduct a Multiple Sclerosis Crime Investigation.

Sameeksha Chopra1,2,3,4, Zoë Myers1,2,3, Henna Sekhon1,2,3, Antoine Dufour1,2,3.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory neurodegenerative autoimmune disease characterized by the aberrant infiltration of immune cells into the central nervous system (CNS) and by the loss of myelin. Sclerotic lesions and various inhibitory factors hamper the remyelination processes within the CNS. MS patients typically experience gradual cognitive and physical disabilities as the disease progresses. The etiology of MS is still unclear and emerging evidence suggests that microbiome composition could play a much more significant role in disease pathogenesis than was initially thought. Initially believed to be isolated to the gut microenvironment, we now know that the microbiome plays a much broader role in various tissues and is essential in the development of the immune system. Here, we present some of the unexpected roles that the microbiome plays in MS and discuss approaches for the development of next-generation treatment strategies.

Entities:  

Keywords:  bacteria; central nervous system (CNS); immunity; microbiome; multiple sclerosis (MS); virus

Year:  2021        PMID: 33801441      PMCID: PMC7958632          DOI: 10.3390/ijms22052498

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  131 in total

Review 1.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

2.  Multimodal Enhancement of Remyelination by Exercise with a Pivotal Role for Oligodendroglial PGC1α.

Authors:  Samuel K Jensen; Nathan J Michaels; Slava Ilyntskyy; Michael B Keough; Olga Kovalchuk; V Wee Yong
Journal:  Cell Rep       Date:  2018-09-18       Impact factor: 9.423

3.  Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10.

Authors:  Olga L Rojas; Anne-Katrin Pröbstel; Elisa A Porfilio; Angela A Wang; Marc Charabati; Tian Sun; Dennis S W Lee; Georgina Galicia; Valeria Ramaglia; Lesley A Ward; Leslie Y T Leung; Ghazal Najafi; Khashayar Khaleghi; Beatriz Garcillán; Angela Li; Rickvinder Besla; Ikbel Naouar; Eric Y Cao; Pailin Chiaranunt; Kyle Burrows; Hannah G Robinson; Jessica R Allanach; Jennifer Yam; Helen Luck; Daniel J Campbell; David Allman; David G Brooks; Michio Tomura; Ryan Baumann; Scott S Zamvil; Amit Bar-Or; Marc S Horwitz; Daniel A Winer; Arthur Mortha; Fabienne Mackay; Alexandre Prat; Lisa C Osborne; Clinton Robbins; Sergio E Baranzini; Jennifer L Gommerman
Journal:  Cell       Date:  2019-01-03       Impact factor: 41.582

4.  Biomarkers of intestinal barrier function in multiple sclerosis are associated with disease activity.

Authors:  Carlos R Camara-Lemarroy; Claudia Silva; Jamie Greenfield; Wei-Qiao Liu; Luanne M Metz; V Wee Yong
Journal:  Mult Scler       Date:  2019-07-18       Impact factor: 6.312

Review 5.  Exercise and the brain in multiple sclerosis.

Authors:  Brian M Lozinski; V Wee Yong
Journal:  Mult Scler       Date:  2020-10-30       Impact factor: 6.312

6.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

Authors:  Kerstin Berer; Lisa Ann Gerdes; Egle Cekanaviciute; Xiaoming Jia; Liang Xiao; Zhongkui Xia; Chuan Liu; Luisa Klotz; Uta Stauffer; Sergio E Baranzini; Tania Kümpfel; Reinhard Hohlfeld; Gurumoorthy Krishnamoorthy; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

7.  Outcomes of natalizumab treatment within 3 years of relapsing-remitting multiple sclerosis diagnosis: a prespecified 2-year interim analysis of STRIVE.

Authors:  Jai Perumal; Robert J Fox; Roumen Balabanov; Laura J Balcer; Steven Galetta; Shavy Makh; Sourav Santra; Christophe Hotermans; Lily Lee
Journal:  BMC Neurol       Date:  2019-06-08       Impact factor: 2.474

8.  Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis.

Authors:  Lorenzo Gaetani; Francesca Boscaro; Giuseppe Pieraccini; Paolo Calabresi; Luigina Romani; Massimiliano Di Filippo; Teresa Zelante
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

9.  Detection of Methanobrevobacter smithii and Methanobrevibacter oralis in Lower Respiratory Tract Microbiota.

Authors:  Yasmine Hassani; Fabienne Brégeon; Gérard Aboudharam; Michel Drancourt; Ghiles Grine
Journal:  Microorganisms       Date:  2020-11-26

10.  Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.

Authors:  Marina Saresella; Ivana Marventano; Monica Barone; Francesca La Rosa; Federica Piancone; Laura Mendozzi; Alessia d'Arma; Valentina Rossi; Luigi Pugnetti; Gabriella Roda; Eleonora Casagni; Michele Dei Cas; Rita Paroni; Patrizia Brigidi; Silvia Turroni; Mario Clerici
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

View more
  1 in total

1.  Proteomics Analysis of Tears and Saliva From Sjogren's Syndrome Patients.

Authors:  Nabangshu Das; Nikhil G Menon; Luiz G N de Almeida; Paige S Woods; Miriam L Heynen; Gregory D Jay; Barbara Caffery; Lyndon Jones; Roman Krawetz; Tannin A Schmidt; Antoine Dufour
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.